Drug Approval | February 15, 2022
Avion Pharmaceuticals announces USFDA approval of DHIVY
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Key takeaways of Q3FY22 quarter & conference call highlights
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
On track to complete the BLA submission in the first half of 2022
MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Subscribe To Our Newsletter & Stay Updated
